Duranest-Mpf
Duranest-Mpf Brand names, Duranest-Mpf Analogs
- Astracaine 4%
- Astracaine 4% Forte
- Carbocaine
- Carbocaine with Neo-Cobefrin
- Chirocaine
- Chlor-Procaine
- Chloroprocain
- Chloroprocaine Hcl
- Chloroprocainum [Inn-Latin]
- Chlorprocaine
- Chlorprocainum
- Citanest Forte
- Citanest Plain
- Cloroprocaina [Inn-Spanish]
- Dalcaine
- Dilocaine
- Duranest
- Duranest-Mpf
- Halestyn
- Isocaine
- Isocaine 2%
- Isocaine 3%
- L-Caine
- Lidoject-1
- Lidoject-2
- Marcaine
- Marcaine Spinal
- Nesacaine
- Nesacaine-Ce
- Nesacaine-Mpf
- Novocain
- Octocaine
- Octocaine-100
- Octocaine-50
- Piocaine
- Polocaine
- Polocaine-Mpf
- Pontocaine
- Sensorcaine
- Sensorcaine Forte
- Sensorcaine-Mpf
- Sensorcaine-Mpf Spinal
- Septocaine
- Ultracaine D-S
- Ultracaine D-S Forte
- Xylocaine
- Xylocaine 5% Spinal
- Xylocaine Test Dose
- Xylocaine-Mpf
- Xylocaine-Mpf with Glucose
Duranest-Mpf Brand Names Mixture
- No information avaliable
Duranest-Mpf Chemical_Formula
C13H19ClN2O2
Duranest-Mpf RX_link
http://www.rxlist.com/cgi/generic3/chloroprocaine.htm
Duranest-Mpf fda sheet
Duranest-Mpf msds (material safety sheet)
Duranest-Mpf Synthesis Reference
No information avaliable
Duranest-Mpf Molecular Weight
270.755 g/mol
Duranest-Mpf Melting Point
No information avaliable
Duranest-Mpf H2O Solubility
665 mg/L
Duranest-Mpf State
Solid
Duranest-Mpf LogP
2.464
Duranest-Mpf Dosage Forms
Liquid
Duranest-Mpf Indication
For the production of local anesthesia by infiltration and peripheral nerve block. They are not to be used for lumbar or caudal epidural anesthesia.
Duranest-Mpf Pharmacology
Chloroprocaine is an anesthetic agent indicated for production of local or regional anesthesia, particularly for oral surgery. Chloroprocaine (like cocaine) has the advantage of constricting blood vessels which reduces bleeding, unlike other local anesthetics like lidocaine. Chloroprocaine is an ester anesthetic.
Duranest-Mpf Absorption
No information avaliable
Duranest-Mpf side effects and Toxicity
No information avaliable
Duranest-Mpf Patient Information
When appropriate, patients should be informed in advance that they may experience temporary loss of sensation and motor activity, usually in the lower half of the body, following proper administration of epidural anesthesia.
Duranest-Mpf Organisms Affected
Humans and other mammals
